FLGT Buybacks
10 quarter-specific issuer repurchase-cash observations normalized from SEC filings, newest first. A filed zero remains visible; a missing filing fact is never converted into zero. This page shows rows 1–10; provenance stays internal.
| Issuer profile | Period end | Type | Reported cash |
|---|---|---|---|
| Fulgent Genetics, Inc. | 2026-03-31 | Reported repurchase cash | $40.08M |
| Fulgent Genetics, Inc. | 2025-12-31 | Reported repurchase cash | $0.00 |
| Fulgent Genetics, Inc. | 2025-03-31 | Reported repurchase cash | $8.68M |
| Fulgent Genetics, Inc. | 2024-12-31 | Reported repurchase cash | $0.00 |
| Fulgent Genetics, Inc. | 2024-03-31 | Reported repurchase cash | $225,000.00 |
| Fulgent Genetics, Inc. | 2023-12-31 | Reported repurchase cash | $22.86M |
| Fulgent Genetics, Inc. | 2022-12-31 | Reported repurchase cash | $29.06M |
| Fulgent Genetics, Inc. | 2021-03-31 | Reported repurchase cash | $513,000.00 |
| Fulgent Genetics, Inc. | 2020-12-31 | Reported repurchase cash | $16,000.00 |
| Fulgent Genetics, Inc. | 2020-03-31 | Reported repurchase cash | $46,000.00 |